Effect of hydrochlorothiazide on the pharmacokinetics of enalapril in hypertensive patients with varying renal function

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 1, 1996, Pages 7-11

  Hersh, Anthony D ^a   Kelly, John G ^b   Laher, Mark S ^c   Carmody, Michael ^c   Doyle, Gerald D ^c  

^a Merck Sharp & Dohme Limited   (United Kingdom)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c BEAUMONT HOSPITAL   (Ireland)

Author keywords

Enalapril; Enalaprilat; Hydrochlorothiazide; Hypertension; Pharmacokinetics; Renal impairment; Safety

Indexed keywords

ENALAPRIL; ENALAPRILAT; HYDROCHLOROTHIAZIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG SAFETY; DRUG TOLERANCE; ENZYME INHIBITION; FEMALE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CROSS-OVER STUDIES; DIURETICS; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; KIDNEY DISEASES; MALE; MIDDLE AGED; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0030031601     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199601000-00002     Document Type: Article

References (19)

1. Todd PA, Heel RC. Enalapril. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension and congestive heart failure. Drugs 1986;31:198-248.
2. Ulm EHL, Hichens M, Gomez HJ, et al. Enalapril maleate and a lysine analogue (ME-521) disposition in man. Br 3 Clin Pharmacol 1982;14:357-64.
3. Kelly JG, O'Malley K. Clinical pharmacokinetics of the newer ACE inhibitors: a review. Clin Pharmacokinet 1990;19:177-96.
4. Singlas E, Fillastre JP. Pharmacokinetics of newer drugs in patients with renal impairment (part II). Clin Pharmacokinet 1991;20:389-410.
5. Oguchi H, Miyasaka M, Koiwai T, et al. Pharmacokinetics of temocapril and enalapril in patients with various degrees of renal insufficiency. Clin Pharmacokinet 1993;24:421-7.
6. Hitchens M, Hand EL, Mulcahy WS. Radioimmunoassay for angiotensin converting enzyme inhibitors. Ligand Q 1981;4:43-50.
7. Grizzle JE. The two-period change-over design and its use in clinical trials. Biometrics 1965;21:467-80.
8. Westlake WJ. Symmetrical confidence intervals for bioequivalence trials. Biometrics 1976;32:741-4.
9. Dahlof B, Bansson L, Acosta JH, et al. Controlled trial of enalapril and hydrochlorothiazide in 200 hypertensive patients. Am J Hypertens 1988;1:38-41.
10. Rosenthal T, Grossman E, Rathaus M, et al. Treatment of hypertension by enalapril and hydrochlorothiazide separately and together: a multicentre study. Isr J Med Sci 1990;26:63-6.
11. Nelson EB, Pool JL, Taylor AA, Mitchel JR. Long term efficacy of enalapril plus hydrochlorothiazide in the treatment of essential hypertension. Clin Pharmacol Ther 1993;33:230-4.
12. Townsend RR, Holland OB. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension. Arch Intern Med 1990;150:1175-83.
13. Kelly JG, Doyle G, Donohue J, et al. Pharmacokinetics of enalapril in normal subjects and patients with renal impairment. Br J Clin Pharmacol 1986;21:63-9.
14. Lowenthal DT, Irvin JD, Merrill D, et al. The effect of renal function on enalapril kinetics. Clin Pharmacol Ther 1985;38:661-6.
15. Weisser K, Schloos J, Jakb S, Muhlberg W, Platt D, Mutschler E. The influence of hydrochlorothiazide on the pharmacokinetics of enalapril in elderly patients. Eur J Clin Invest 1992;43:173-7.
16. Gomez HJ, Cirillo VJ, Irvin JD. Enalapril: a review of human pharmacology. Drugs 1985;30(suppl 1): 13-24.
17. Krum H, Jackson B, Conway EL, Howes LG, Johnston CI, Louis WJ. Steady state pharmacokinetics and pharmacodynamics of cilazapril in the presence and absence of cyclopenthiazide. J Cariovasc Pharmacol 1992;20:451-7.
18. Swaisland AJ. The pharmacokinetics of co-administered lisinopril and hydrochlorothiazide. J Hum Hypertens 1991;5(suppl 2):69-71.
19. Laher MS, Mulkerrin E, Hosie J, Connell PA, Smith RP, Swaisland AJ. The effects of age and renal impairment on the pharmacokinetics of co-administered lisinopril and hydrochlorothiazide. J Hum Hypertens 1991;5(suppl 2):77-80.